NASDAQ:HSKA Heska (HSKA) Stock Price, News & Analysis → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free HSKA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$119.99▼$119.9950-Day Range$115.55▼$119.9952-Week Range$57.83▼$120.03VolumeN/AAverage Volume241,932 shsMarket Capitalization$1.31 billionP/E RatioN/ADividend YieldN/APrice Target$120.00 Stock AnalysisStock Analysis Get Heska alerts: Email Address Ad Crypto Swap ProfitsGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Heska Stock (NASDAQ:HSKA)Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.Read More Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. HSKA Stock News HeadlinesJanuary 2, 2024 | marketwatch.comVolitionRx Shares Up 35% on $13M Milestone Payments From HeskaOctober 31, 2023 | thestreet.comWhy Heska (HSKA) Hit a One-Year High TodayMarch 28, 2024 | Crypto 101 Media (Ad)Crypto Market Preps For Trillions Worth of Inflows! Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.June 8, 2023 | markets.businessinsider.comWhy eXp World Holdings Shares Are Rising ThursdayMay 19, 2023 | msn.comHeska Earnings Perspective: Return On Capital EmployedMay 11, 2023 | businesswire.comHESKA CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Heska ...May 9, 2023 | finance.yahoo.comStrong Fourth Quarter Results Supported Heska Corporation (HSKA) in Q1May 5, 2023 | finance.yahoo.comHeska (HSKA) Q1 Earnings and Revenues Lag EstimatesMarch 28, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. May 5, 2023 | finance.yahoo.comHeska Corporation Reports First Quarter 2023 ResultsApril 21, 2023 | finance.yahoo.comHeska Announces Annual Meeting of Stockholders on May 3, 2023April 4, 2023 | finance.yahoo.comThe three-year returns have been strong for Heska (NASDAQ:HSKA) shareholders despite underlying losses increasingApril 3, 2023 | finance.yahoo.comWhy Heska Stock Is On Fire TodayApril 3, 2023 | finance.yahoo.comMars to Acquire Heska, Global Provider of Advanced Veterinary Diagnostic and Specialty SolutionsMarch 1, 2023 | finance.yahoo.comHeska (HSKA) Q4 Earnings and Revenues Surpass EstimatesMarch 1, 2023 | finance.yahoo.comHeska Full Year 2022 Earnings: EPS Misses ExpectationsMarch 1, 2023 | finance.yahoo.comAt US$81.43, Is It Time To Put Heska Corporation (NASDAQ:HSKA) On Your Watch List?February 28, 2023 | finance.yahoo.comHeska Corporation Reports Fourth Quarter and Full Year 2022 ResultsFebruary 23, 2023 | finance.yahoo.comHeska to Present at Three Upcoming Institutional Investor ConferencesFebruary 13, 2023 | finance.yahoo.comHeska (HSKA) Moves to Buy: Rationale Behind the UpgradeFebruary 8, 2023 | finance.yahoo.comHeska Fourth Quarter and Full Year 2022 Financial Results and Earnings Call Scheduled for February 28, 2023January 18, 2023 | finance.yahoo.comIs There An Opportunity With Heska Corporation's (NASDAQ:HSKA) 50% Undervaluation?January 12, 2023 | gurufocus.comHeska Corp's CEO Loads Up on Shares After 70% NosediveJanuary 11, 2023 | finance.yahoo.comHeska (HSKA) Moves 9.0% Higher: Will This Strength Last?January 3, 2023 | finance.yahoo.comHeska Corporation Completes Acquisition of LightDeck DiagnosticsDecember 23, 2022 | finance.yahoo.comHeska to Participate in the 41st J.P. Morgan Annual Healthcare ConferenceNovember 8, 2022 | finance.yahoo.comHeska Corporation Reports Third Quarter 2022 ResultsSee More Headlines Receive HSKA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Heska and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolNASDAQ:HSKA CUSIPN/A CIK1038133 Webwww.heska.com Phone(970) 493-7272Fax970-619-3003Employees808Year FoundedN/APrice Target and Rating Average Stock Price Target$120.00 High Stock Price Target$120.00 Low Stock Price Target$120.00 Potential Upside/Downside+0.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.93) Trailing P/E RatioN/A Forward P/E Ratio266.64 P/E GrowthN/ANet Income$-19,890,000.00 Net Margins-7.86% Pretax Margin-7.91% Return on Equity0.94% Return on Assets0.67% Debt Debt-to-Equity Ratio0.23 Current Ratio5.64 Quick Ratio4.12 Sales & Book Value Annual Sales$257.31 million Price / Sales5.09 Cash Flow$1.69 per share Price / Cash Flow70.99 Book Value$39.00 per share Price / Book3.08Miscellaneous Outstanding Shares10,910,000Free Float9,572,000Market Cap$1.31 billion OptionableNot Optionable Beta1.58 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Kevin S. Wilson (Age 51)CEO, Pres & Director Comp: $988.17kMs. Catherine I. Grassman CPA (Age 47)Exec. VP & CFO Comp: $536.46kMr. Christopher D. Sveen (Age 40)EVP, Chief Admn. Officer, Gen. Counsel, Corp. Sec. & Pres of Diamond Animal Health Comp: $457.89kMr. Steven M. Eyl (Age 57)Exec. VP, Chief Commercial Officer & Pres of scil animal care company Comp: $475.28kMs. Eleanor F. Baker (Age 38)Exec. VP, MD & COO of Scil Animal Care Company Comp: $467.77kMr. Jon AagaardDirector of Investor RelationsMr. Anthony C. Providenti Jr. (Age 56)Exec. VP of Corp. Devel. Dr. Nancy Wisnewski Ph.D. (Age 60)Chief Science Advisor to CEO Daniel J. PollackVP of Imaging Operations, Treasurer & Assistant Sec.Cynthia PattersonVP of Customer CareMore ExecutivesKey CompetitorsEargoNASDAQ:EARIronwood PharmaceuticalsNASDAQ:IRWDXencorNASDAQ:XNCRPacira BioSciencesNASDAQ:PCRXMannKindNASDAQ:MNKDView All Competitors HSKA Stock Analysis - Frequently Asked Questions Should I buy or sell Heska stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Heska in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HSKA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSKA, but not buy additional shares or sell existing shares. View HSKA analyst ratings or view top-rated stocks. What is Heska's stock price target for 2024? 2 Wall Street research analysts have issued 1 year price targets for Heska's stock. Their HSKA share price targets range from $120.00 to $120.00. On average, they predict the company's share price to reach $120.00 in the next year. This suggests a possible upside of 0.0% from the stock's current price. View analysts price targets for HSKA or view top-rated stocks among Wall Street analysts. How were Heska's earnings last quarter? Heska Co. (NASDAQ:HSKA) posted its quarterly earnings data on Thursday, November, 4th. The medical research company reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of $0.04 by $0.23. The medical research company had revenue of $60.24 million for the quarter, compared to the consensus estimate of $63.80 million. Heska had a negative net margin of 7.86% and a positive trailing twelve-month return on equity of 0.94%. The firm's quarterly revenue was up 6.4% on a year-over-year basis. During the same period last year, the business earned ($0.25) earnings per share. What is Kevin S. Wilson's approval rating as Heska's CEO? 5 employees have rated Heska Chief Executive Officer Kevin S. Wilson on Glassdoor.com. Kevin S. Wilson has an approval rating of 57% among the company's employees. This puts Kevin S. Wilson in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Heska own? Based on aggregate information from My MarketBeat watchlists, some companies that other Heska investors own include Gilead Sciences (GILD), Exxon Mobil (XOM), Netflix (NFLX), Biogen (BIIB), AbbVie (ABBV), Amgen (AMGN), Broadcom (AVGO), Alibaba Group (BABA), Exelixis (EXEL) and Merck & Co., Inc. (MRK). This page (NASDAQ:HSKA) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heska Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.